Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine.

< BACK TO ARCHIVE


Papers: 15 Feb 2025 - 21 Feb 2025


2025 Feb 19


J Headache Pain


39972460


26


1

The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine.

Authors

Suzuki K, Suzuki S, Fujita H, Kobayashi S, Shioda M, Hida R, Hirata K

Abstract

Calcitonin gene-related peptide monoclonal antibody (CGRP mAb) effects on restless legs syndrome (RLS) are unclear.
Read This Paper